Giant drug deal: Bristol-Myers Squibb buying Celgene for $74 billion By: New York Business Journal via Business Journals January 03, 2019 at 09:32 AM EST Bristol-Myers Squibb said the deal will strengthen its cancer and inflammatory disease drug products. Read More >>